. Leaves of the betel plant (P. betle) are commonly used as a wrapper for chewing psychoactive areca nut in South Asia. Betel leaves accumulate several specialized allylphenols, including chavibetol and hydroxychavicol, which may act as antimutagens that counteract the carcinogenic effect of the areca nut while enhancing its psychoactive effect 6, 7 . The kava plant (P. methysticum; Fig. 1a ) is native to the Polynesian islands, together with species under the subgenus Macropiper, forming a South Pacific clade of Piper plants phylogenetically distant from Piper plants from Asia 8 . Throughout the Polynesian indigenous cultures, kava root is prepared as a beverage and consumed for its unique sedative and anaesthetic effects in religious and cultural rituals. Its anxiolytic and analgesic properties are supported by over 3,000 years of traditional use, as well as numerous recent clinical trials [9] [10] [11] [12] . The bioactive ingredients of kava are phenolic polyketides collectively known as kavalactones (labelled here as 1-20; Supplementary Fig. 1a ). Kava roots can contain up to 15% kavalactones by dry weight 13 , whereby a person can ingest several grams of kavalactones during one traditional kava drinking session. Although some concerns were raised in the past about potential hepatotoxicity of kava, it is now generally accepted that the several reported toxicity cases arose from other causative factors rather than kavalactones 14 . Due to its unique anxiolytic effect and generally safe nature, kava drinking has gained popularity worldwide in recent years. Over 100 kava bars are now operating throughout the United States 15 and some athletes have embraced kava as a safe and non-addictive remedy for pain management 16 . Kavalactones interact with the human central nervous system through mechanisms distinct from those of common prescription psychiatric drugs, such as benzodiazepines or opioids, and therefore show promise to be developed into pharmaceuticals for treating anxiety, insomnia and pain 17, 18 . Despite the worldwide consumption of kava as a sedative beverage and the potential of kavalactones to be developed as anxiolytic medicines, the biosynthesis pathway of kavalactones is unknown. Here, we find key enzymes involved in the biosynthesis of structurally diverse kavalactones in kava and trace their evolutionary origins in other, more conserved, metabolic pathways. We also show it is feasible to use these newly discovered catalysts to engineer microbes to produce styrylpyrones as an alternative means to access these high-value natural products.
The biosynthetic proposal for kavalactones. To investigate kavalactone biosynthesis, we first surveyed the taxonomic distribution of kavalactones in the Piper genus by untargeted metabolomics. Total methanolic extracts from kava and four other Piper species were analysed by liquid chromatography-high-resolution accuratemass mass-spectrometry (LC-HRAM-MS). While kavalactones are among the most abundant metabolites present in kava extract, they are absent in P. nigrum, P. betle, P. auritum and P. sarmentosum (Fig. 1b) , suggesting that kavalactone biosynthesis probably emerged after kava diverged from other Piper species. In addition to kavalactones, we also detected flavokavain A, B and C in kava, three previously characterized chalconoids with reported anticancer properties 19, 20 (21) (22) (23) ; Fig. 1b and Supplementary Fig. 1b ). Considering the structural relationship between kavalactones and flavokavains, which feature the styrylpyrone and chalcone backbones, respectively, we hypothesized that kavalactone biosynthesis probably involves styrylpyrone synthase (SPS), a polyketide synthase (PKS) The biosynthetic origin of psychoactive kavalactones in kava Tomáš Pluskal 1 related to chalcone synthase (CHS). CHS catalyses the first committed enzymatic step in flavonoid biosynthesis and is ubiquitously present in land plants 21 ( Fig. 1c) . Like CHS, SPS would accept a 4-coumaratecoenzyme A (CoA) ligase (4CL)-generated hydroxycinnamoyl-CoA thioester (for example, p-coumaroyl-CoA) as a starter substrate; and catalyse iterative decarboxylative condensations of two-carbon ketone units derived from its co-substrate, malonyl-CoA. While CHS produces a tetraketide intermediate that further cyclizes via Claisen condensation to yield the chalcone backbone, SPS would yield a triketide intermediate that lactonizes to form the styrylpyrone backbone (Fig. 1c) . Additional tailoring enzymes, such as O-methyltransferases (OMTs) and oxidoreductases, are necessary to further decorate the initial scaffolds to give rise to the full repertoire of kavalactones and flavokavains present in kava plants ( Supplementary Fig. 1 ).
Kava contains two styrylpyrone synthases.
Kava is a decaploid (2n = 10x = 130 chromosomes) 22 , rendering biosynthetic enquiry via conventional genetic approaches infeasible. We therefore turned to a multiomics-guided candidate gene approach [23] [24] [25] . We first identified three CHS-like genes in a kava transcriptome assembled de novo from leaf and root tissues (Supplementary Table 1 ). Phylogenetic analysis of these genes in the context of other land-plant CHSs suggests that two of the three genes were probably derived from recent gene duplication events specific to kava (Fig. 2a) . In vitro enzyme assays using heterologously expressed and purified enzymes established that these two CHS-like genes encode functional SPSs. Both enzymes exclusively produce the triketide lactone bisnoryangonin (25; Supplementary Note 1) from p-coumaroyl-CoA (Fig. 2b) and are therefore named PmSPS1 and PmSPS2 hereafter (where Pm signifies P. methysticum). The assay also suggested that the third CHS-like gene encodes a bona fide CHS, as it was the only enzyme capable of producing the expected tetraketide-derived naringenin chalcone (27) and we refer to it as PmCHS hereafter (Fig. 2b) . It is noted that in comparison to naringenin chalcone, PmCHS produced substantially more p-coumaroyltriacetic acid lactone (CTAL; 28) and bisnoryangonin (25) in vitro. Although such derailment products have been reported for a number of previously characterized CHSs (refs. 26, 27 ), PmCHS seems to be atypical in the sense that CTAL and bisnoryangonin are its major products in vitro, while naringenin chalcone is a minor product. To assess the in vivo function of the three newly identified kava PKSs, we expressed each of them as stable transgenes in the Arabidopsis thaliana CHS-null mutant tt4-2 background 28 . Whereas PmCHS restored flavonoid biosynthesis in tt4-2, neither PmSPS1 nor PmSPS2 did, consistent with their respective in vitro biochemical activities (Supplementary Fig. 2 by X-ray crystallography (Supplementary Table 2 ; ligand omit maps in Supplementary Fig. 3 ). Both proteins are homodimers and share the canonical αβαβα thiolase fold typical for plant type III PKSs 21 ( Fig. 2c) . Evolutionary analysis using the Mixed Effects Model of Evolution (MEME) 30 on the ancestral branch of kava SPSs (Fig. 2a ) detected six amino acid residues under episodic diversifying selection (P < 0.05) ( Supplementary Fig. 4 ). Three of these substitutions, S133C, T198N and Q213L, are mapped to the enzyme active site (Fig. 2d) . Notably, the T198N substitution was previously reported as one of the three mutations sufficient to convert CHS into a 2-pyrone synthase (2PS; ref. 31 ). We also observed an unusual insertion of threonine (T194) in a loop region abutting the active site, together with the S133C substitution, causing a reduction of the PmSPS1 active site volume compared to PmCHS in the direction along the polyketide chain elongation (Fig. 2e) . In comparison, the previously reported Rheum palmatum benzalacetone synthase (RpBAS), which catalyses only a single round of ketide elongation 32 , features a further shortened active site compared to PmSPS1 (Fig. 2e) . These observations therefore support the notion that subtle changes of active-site volume and shape of type III PKSs dictate the iterative cycles of polyketide elongation and alternative cyclization mechanisms 33 . In addition, we observed two different conformations of T194 among the six protomers present in the asymmetric unit, indicating the dynamic nature of the underlying loop and its potential role in the catalytic cycle of PmSPS1 (Fig. 2f) . One of the protomers in our PmSPS1-p-coumaroyl-CoA complex structure also captures a p-coumaroyl-monoketide intermediate covalently bound to the catalytic cysteine (Fig. 2f ), providing a rare glimpse of the activesite configuration after the starter substrate loading step of the PKS catalytic cycle 33 . Homology modelling and sequence analysis of PmSPS2 suggest that its active site contains a similar set of amino acid substitutions as observed in PmSPS1, except for the T194 insertion ( Supplementary Figs. 4 
and 5).
Although PmSPS1 and PmSPS2 seem redundant in their in vitro activity, we proposed that they may exhibit differences in substrate preference. In vitro assays in the presence of equimolar mixture of six different acyl-CoAs as starter substrates revealed substantial differences in substrate preference among the three kava PKSs (Supplementary Note 3). Whereas PmSPS1 preferentially produces 11-methoxy-bisnoryangonin (39) and 4-hydroxy-6-styryl-2-pyrone (24) from feruloyl-CoA and cinnamoyl-CoA, respectively, PmSPS2 produces mostly dihydrobisnoryangonin (35) Fig. 1a ). We hypothesized that kavalactone-biosynthetic OMTs might have been recruited from more conserved OMTs involved in plant phenylpropanoid metabolism; for example, the caffeic acid O-methyltransferase in lignin biosynthesis 34 . Combining phylogenomics and expression analysis, we identified six putative OMT candidate genes from the kava transcriptome (Supplementary Table 1 ). Since kavalactones contain four possible O-methylation sites (-OH groups at the C4, C10, C11 or C12 positions), we established a coupled enzymatic system using a 4CL enzyme cloned from kava (designated Pm4CL1) and PmSPS1 to produce five styrylpyrones featuring different aromatic ring modification patterns derived from five hydroxycinnamic acids, namely cinnamic, p-coumaric, caffeic, ferulic and umbellic acid (Supplementary Note 4). Subsequent OMT activity assays using recombinant kava OMTs revealed that two of the six kava OMT candidates showed activity against various styrylpyrones ( Fig. 3a) and were thus named kava O-methyltransferases 1 and 2 (PmKOMT1 and PmKOMT2), respectively. PmKOMT1 is one of the most highly expressed enzymes according to the abundance of its corresponding transcript in the kava transcriptome (Supplementary Table 1 ) and is capable of methylating the -OH groups at the C4, C11 or C12 positions of the styrylpyrone backbone. On the other hand, PmKOMT2 activity is specific to the -OH group attached at the C10 position (Fig. 3a) . Transient co-expression of PmKOMT1 together with PmSPS1 or PmSPS2 in N. benthamiana resulted in the production of yangonin, a kavalactone with two methoxy groups at the C4 and C12 positions (Fig. 3b) , supporting the enzymatic activities observed in vitro. This result also suggests that O-methylation protects styrylpyrones produced by kava SPSs from being catabolized in N. benthamiana.
Biosynthesis of 7,8-saturated kavalactones.
The styrylpyrone backbones produced by SPSs from hydroxycinnamic acids contain two olefins (C5=C6 and C7=C8), whereas a number of naturally occuring kavalactones possess alkane at either position (for example, kavain with C5-C6 or 7,8-dihydroyangonin with C7-C8) or both positions (for example, 7,8-dihydrokavain; Supplementary Fig. 1a ). We proposed that the 7,8-saturated kavalactones could be derived from dihydro-hydroxycinnamoyl-CoA precursors already containing a reduced α−β bond. This proposal was provoked by previous reports that two type III PKSs in the genera Pinus and Malus can accept dihydro-p-coumaroyl-CoA as a starter substrate to produce 5-hydroxylunularic acid and phloretin, respectively 35, 36 . To test this, we performed coupled Pm4CL1−PmSPS1 in vitro enzyme assays using phloretic acid and phenylpropanoic acid as starter substrates, both of which contain a reduced α−β bond. These assays resulted in the production of the corresponding 7,8-saturated kavalactones, suggesting that Pm4CL1 and PmSPS1 can use substrates derived from dihydro-hydroxycinnamic acids with a reduced α−β bond ( Supplementary Fig. 6 ). Although dihydro-hydroxycinnamic acids are widespread in plants 37, 38 , the mechanism underlying (hydroxy) cinnamic acid α−β olefin reduction is yet to be characterized.
Reduction of 5,6-olefin in kavain-like kavalactones. While 7,8-dihydro-kavalactones can be derived from dihydro-hydroxycinnamic acids, reduction of the 5,6-olefin has to occur after the styrylpyrone backbone is formed by SPS. Moreover, the 5,6-olefin reduction is stereo-specific, suggesting that this reaction is probably enzyme-catalysed. Using similar approaches as for the discovery of kava OMTs, we identified 12 kava reductases that are homologous to various known reductases in plant specialized metabolism (Supplementary Table 1 ). By transgenic co-expression of each of these reductase candidates together with PmSPS1 and PmKOMT1 in N. benthamiana, we identified a single reductase candidate that produces metabolites with mass spectra corresponding to styrylpyrones with the 5,6-olefin reduced to alkane (Supplementary Note 5). We named this enzyme kavalactone reductase 1 (PmKLR1). A combined enzyme assay using purified Pm4CL1, PmSPS1, PmKOMT1 and PmKLR1 enzymes starting from cinnamic acid successfully produced kavain in vitro (Fig. 4a) . We determined, using chiral chromatography, that PmKLR1 produces only (R)-(+)-kavain, the same stereoisomer as present in kava root extract (Fig. 4b) .
Since PmKLR and PmKOMT1 probably compete for common intermediates, we sought to determine the catalytic order of these two enzymes. We first conducted an isotopic tracing experiment by incubating a piece of live kava root with deuteriumlabelled styrylpyrone precursors with or without 4-O-methylation ( Supplementary Fig. 7a ). This experiment shows that PmKLR1 can only accept the unmethylated styrylpyrone precursor in vivo. Subsequent in vitro enzyme assays further corroborated this observation ( Supplementary Fig. 7b ). On the other hand, PmKOMT1 is permissive towards styrylpyrone substrates regardless of whether the 5,6-olefin is reduced or not ( Supplementary Fig. 7b ). We therefore conclude that PmKLR1 competes with PmKOMT1 for the same styrylpyrone substrates, but is unable to reduce the 5,6-olefin once the 4-O-methylation has occurred, providing an explanation to the fact that only a fraction of the major kavalactones contain the reduced C5−C6 bond ( Supplementary Fig. 1a ).
Phylogenetic analysis of PmKLR1 together with several related reductases from A. thaliana suggests that PmKLR1 probably originated from an ancestral cinnamoyl-CoA reductase (Fig. 4c) . To further dissect the structural basis for the reaction mechanism and regio-and stereo-selectivity of PmKLR1, we solved its holo structure in complex with nicotinamide adenine dinucleotide phosphate (NADP + ) by X-ray crystallography (Supplementary Table 2 ; ligand . The substrate 4-hydroxy-6-styryl-2-pyrone (24) was computationally docked into the active site, where Tyr 194 was set as flexible. e, A detailed view of PmKLR1 active site, highlighting several key residues involved in substrate binding and catalysis. f, Mass spectra of kavain (1) produced by an in vitro enzyme assay using Pm4CL1, PmSPS1, PmKLR1 and PmKOMT1 enzymes starting from cinnamic acid. NADPH and deuterium-labelled NADPH isotopic analogues (R)-NADPD and (S)-NADPD were used as co-substrates for PmKLR1. Independent experiments, n = 2. g, The proposed catalytic mechanism of PmKLR1.
omit maps in Supplementary Fig. 8 ) and computationally docked a styrylpyrone substrate, 4-hydroxy-6-styryl-2-pyrone (24), into its active site (Fig. 4d) . The PmKLR1 structure reveals features of the substrate-binding pocket probably responsible for the regio-and stereo-selective reduction of the styrylpyrone 5,6-olefin (Fig. 4e) . The docked styrylpyrone substrate is coordinated by several active-site-lining residues to adopt a specific binding pose, and indicates that the hydride from the nicotinamide group of NADPH is transferred to C5. Lys 169 and Tyr 165 coordinate the binding of NADPH by hydrogen bonding with its ribosyl -OH groups, while Lys 169 probably also serves as a proton donor that relays its sidechain amine proton through Ser 128 to C6 of the styrylpyrone substrate exclusively from one side of the lactone ring (Fig. 4e) . As the 5,6-olefin is reduced to alkane, a new chiral centre at C6 is formed. The intricate hydrogen bonds between the styrylpyrone 4-OH, Ser 128 and Thr 129 further corroborates our previous observations that 4-O-methylated styrylpyrone substrates would not bind properly and productively to the PmKLR1 active site. To experimentally examine the roles of these residues, we generated several PmKLR1 mutants: Y165F, K169A, K169M, S128A and T129A. In vitro enzyme assays using these mutant proteins showed that all residues but Thr 129 are essential for the catalytic activity of PmKLR1 (Supplementary Fig. 9 ). In addition, using synthesized NADPH isotopic analogues with deuterium labelling at either pro-S or pro-R position of the nicotinamide group (Supplementary Fig. 10 ), we show unequivocally that the pro-S-hydride of NADPH is transferred to the styrylpyrone substrate by PmKLR1 (Fig. 4f) , which is in agreement with the relative configuration of the docked substrate and NADP + in PmKLR1 active site (Fig. 4e) . On the basis of these results, we outline the catalytic mechanism of PmKLR1 (Fig. 4g) .
Methysticin synthase installs a methylenedioxy bridge.
Methysticin-like kavalactones, which carry a methylenedioxy bridge at the C11−C12 position ( Supplementary Fig. 1a) , exhibit strong modulatory effects on human liver cytochromes P450 and thus contribute to the complex pharmacology of kava 39 . The CYP719 family of plant P450 enzymes is known to catalyse the formation of the methylenedioxy bridge moiety from vicinal methoxy and hydroxy groups; for example, in the biosynthesis of berberine and etoposide 40, 41 . We identified a single gene of the CYP719 family in kava, PmCYP719A26 (Fig. 5a ) and suggested that it may catalyse the formation of methylenedioxy bridge using ferulic acid-derived styrylpyrone precursors carrying vicinal 11-methoxy and 12-hydroxy groups (Fig. 5b) . Indeed, co-expression of PmSPS1, PmKOMT1 and PmCYP719A26 in N. benthamiana resulted in the transgenic production of a compound with the molecular mass and retention time identical to that of methysticin (5; Fig. 5c ). On the basis of a tandem mass spectrometry (MS/MS) fragmentation pattern comparison with a methysticin standard, we tentatively assigned this compound as 5,6-dehydro-7,8-dihydromethysticin (47; Supplementary Note 6). We therefore designated PmCYP719A26 as methysticin synthase 1 (PmMTS1).
Flavokavain biosynthesis uses the same KOMTs. Through OMT activity screen, we found that PmKOMT1 and PmKOMT2 also exhibit O-methylation activities against naringenin chalcone produced by CHS (Supplementary Note 7) . Using enzyme assays and heterologous expression in N. benthamiana, we confirmed that PmKOMT1 methylates the hydroxy groups at the C4 and C4ʹ positions on the chalcone scaffold, whereas PmKOMT2 methylates the hydroxy group at the C2ʹ position ( Supplementary Fig. 11 ). We thus established that the three known flavokavains ( Supplementary  Fig. 1b) can be produced by the combined activities of PmCHS, PmKOMT1 and PmKOMT2.
Heterologous production of styrylpyrones in microorganisms.
As a proof of concept, we examined the feasibility of kavalactone production in microbial hosts through the means of metabolic engineering. Using an operon-like construct co-expressing Pm4CL1 together with PmSPS1 or PmSPS2 under the constitutive pGAP promoter, we could reconstitute the biosynthesis of the kavalactone precursor, bisnoryangonin, from supplemented p-coumaric acid in Escherichia coli under shake flask conditions ( Supplementary  Fig. 12a) . Similarly, plasmid-based expression of the same combination of enzymes under the constitutive pTEF promoter in the yeast Saccharomyces cerevisiae also resulted in bisnoryangonin production from supplemented p-coumaric acid under shake flask conditions ( Supplementary Fig. 12b ). Future efforts in combining kavalactone-biosynthetic genes with previously developed background bacterial or yeast strains over-producing p-coumaroyl-CoA can potentially further increase the titre of kavalactone production in these hosts 42 .
Discussion
Plant type III PKSs descended from the ancestral 3-ketoacyl-acyl carrier protein synthase III (KAS III) enzymes involved in fatty acid metabolism. They have radiated during land plant evolution to give rise to a diverse class of specialized metabolic enzymes responsible for producing a battery of important polyketide scaffolds, including chalcones, stilbenes (for example, resveratrol), benzalacetones and others 21 . Polyketide natural products stemmed from these scaffolds contribute to the fitness of their plant hosts amid unique selective pressures present in diverse terrestrial environmental niches. Plant natural products that carry the styrylpyrone structural motif have been known for decades 43 but our study presents molecular cloning and functional characterization of two dedicated SPSs from a styrylpyrone-producing plant. Notable SPS activity was observed in PmCHS, which represents the extant version of the evolutionary Supplementary Fig. 1a . Enzymatic activities elucidated in this study are indicated with red arrows. The mechanism of the reduction of the α-β olefin in phenylpropanoid metabolism (green panel) is unclear but dihydro-hydroxycinnamic acids are widespread in plants 37, 38 . The preference of PmSPS1, PmSPS2 and PmCHS enzymes for styrylpyrone biosynthesis (pink panel) is shown on the basis of the determined substrate preference (Supplementary Note 3) . HCT, hydroxycinnamoyltransferase; C3ʹH, p-coumaroyl shikimate 3ʹ-hydroxylase; CSE, caffeoyl shikimate esterase; C2H, coumarate 2-hydroxylase; CNL, cinnamate-CoA ligase; COMT, caffeic acid O-methyltransferase; CCoAOMT, caffeoyl-CoA O-methyltransferase.
progenitor that gave rise to PmSPS1 and PmSPS2. The latent SPS activity of PmCHS probably resulted in the initial serendipitous accumulation of styrylpyrones at appreciable amount in the ancestors of kava, which kick-started the natural selection process that further shaped the evolutionary trajectory of these newly emerged metabolic traits 44, 45 . Mainly through the mechanism of gene duplication followed by neofunctionalization, two dedicated SPSs as well as additional kavalactone-biosynthetic tailoring enzymes evolved from progenitor enzymes in pre-existing pathways. These evolutionarily new enzymes assembled into a metabolic network (Fig. 6) to produce the full repertoire of kavalactones as observed in extant kava cultivars today. Although the biosynthetic origin of kavalactones as delineated in this study is unique to kava, it epitomizes a common evolutionary process underpinning the rapid expansion of specialized metabolism in the plant kingdom 46 . Given the psychoactive properties of kavalactones, evolutionary exploration of the variety of naturally occuring kavalactones probably conferred protection in kava against herbivorous animals. Consistent with this notion, folk stories about small rodents paralyzed by chewing on the roots of kava plants are widespread in the Pacific islands. It is also likely that the thousands of years of consumption and cultivation of kava plants by Polynesian islanders have led to human artificial selection of kava plants that produce higher content and specific composition of kavalactones.
In animals, kavalactones display complex pharmacology, including modulation of GABA A and cannabinoid (CB 1 ) receptors, blockade of voltage-gated sodium ion channels, reduced release and reuptake of neurotransmitters and interactions with monoamine oxidase B (refs. 11, 12 ). In particular, kavain was shown to act as a positive allosteric modulator of the GABA A receptor through a binding site different from that of benzodiazepine psychiatric drugs 17 . The capability to produce structurally diverse kavalactones and their derivatives by metabolic engineering of the biosynthetic enzymes described herein will help delineate the structure-function relationships of kavalactones and potentially lead to biomedical applications. In light of several major challenges facing modern society, such as anxiety, opioid crisis and the scarcity of effective treatments for psychiatric disorders, kavalactones and their derivatives present a promising class of psychoactive molecules to potentially answer these unmet needs. RNA extraction and complementary DNA template preparation. Total RNA was extracted separately from kava root and leaf tissue using the RNeasy Plant Mini Kit (QIAGEN). First-strand cDNAs were synthesized by PCR with reverse transcription from the total RNA samples as templates using the SuperScript III First-Strand Synthesis System with the oligo(dT) 20 primer (Thermo Fisher Scientific).
Methods

Chemicals
Transcriptome sequencing and assembly. The transcriptome library preparation and sequencing were performed at the Beijing Genomics Institute using the standard BGISEQ-500 RNA sample preparation protocol. The libraries were sequenced as 50 × 50 base pair (bp) (PE-50) reads on the BGISEQ-500 platform. Sequence reads (FASTQ files) from leaf and root samples were merged into a single set of reads, trimmed for sequencing adaptors using Trimmomatic 47 and assembled into a de novo transcriptome using Trinity 48 , resulting in 285,753 transcript sequences. In those, we identified 302,366 putative open reading frames using Transdecoder 49 . We evaluated the transcriptome as 78.6% complete by the metric of Benchmarking Universal Single-Copy Orthologs 50 . Gene expression statistics were determined using RSEM 51 . Transcripts and predicted protein sequences were annotated with transcript-per-million (TPM) values and closest BLAST hits from the UniProtKB/Swiss-Prot database using in-house scripts.
Transcriptome mining was performed on a local BLAST server 52 . In addition, two kava root RNA-seq datasets previously published by the PhytoMetaSyn Project 53 (NCBI SRA accessions SRX202785 and SRX202184) were assembled and used as complementary sources of candidate enzyme sequences. Existing RNA-seq datasets of P. auritum, P. betle and P. nigrum (NCBI SRA accessions ERX2099199, SRX691517 and SRX890122) were also assembled into de novo transcriptomes to obtain their corresponding CHS sequences.
Sequence alignment and phylogenetic analyses. Sequence alignments were performed using the MUSCLE 54 algorithm in MEGA7 (ref.
55
). Evolutionary histories were inferred by using the maximum-likelihood method on the basis of the JTT matrix-based model 56 . Bootstrap values were calculated using 1,000 replicates. All phylogenetic analyses were conducted in MEGA7 (ref. 55 ).
Evolutionary analysis. The MEME analysis 30 was performed via the Hypothesis Testing using Phylogenies (HyPhy) package 57 , starting from codon-aligned CHS nucleotide sequences and the corresponding phylogenetic tree. The P-value threshold was set to 0.05.
Cloning of candidate genes from cDNA. Phusion High-Fidelity DNA Polymerase (Thermo Fisher Scientific) was used for PCR amplifications from kava cDNA. Gibson assembly was used to clone the amplified genes into target vectors 58 . Restriction enzymes and Gibson assembly reagents were purchased from New England Biolabs. Oligonucleotide primers were purchased from Integrated DNA Technologies. All primers used for cloning are listed in Supplementary Table 4 .
Protein expression and purification. Candidate genes were cloned into pHis8-4, a bacterial expression vector containing an N-terminal 8× His tag followed by a tobacco etch virus (TEV) cleavage site for recombinant protein production in E. coli. Proteins were expressed in the BL21(DE3) E. coli strain cultivated in terrific broth (TB) and induced with 0.1 mM isopropyl β-d-1-thiogalactopyranoside (IPTG) overnight at 18 °C. For the OMT enzyme screen, crude protein extracts were prepared from E. coli cultures using Bacterial Protein Extraction Reagent (Thermo Fisher Scientific). For protein purification, E. coli cells were harvested by centrifugation, resuspended in 150 ml lysis buffer (50 mM Tris buffer pH 8.0, 500 mM NaCl, 30 mM imidazole, 5 mM dithiothreitol) and lysed with five passes through an M-110L microfluidizer (Microfluidics). The resulting crude protein lysate was clarified by centrifugation (19,000g, 1 h) before QIAGEN nickelnitrilotriacetic acid (Ni-NTA) gravity flow chromatographic purification. After loading the clarified lysate, the Ni-NTA resin was washed with 20 column volumes of lysis buffer and eluted with 1 column volume of elution buffer (50 mM Tris buffer pH 8.0, 500 mM NaCl, 300 mM imidazole, 5 mM dithiothreitol). Then 1 mg of His-tagged TEV protease 59 was added to the eluted protein, followed by dialysis at 4 °C for 16 h in dialysis buffer (50 mM Tris buffer pH 8.0, 500 mM NaCl, 5 mM dithiothreitol). After dialysis, protein solution was passed through Ni-NTA resin to remove uncleaved protein and His-tagged TEV. The recombinant proteins were further purified by gel filtration on an ÄKTA fast protein liquid chromatography (FPLC) system (GE Healthcare Life Sciences). The principal peaks were collected, verified by SDS polyacrylamide gel electrophoresis and dialysed into a storage buffer (12.5 mM Tris buffer pH 8.0, 50 mM NaCl, 5 mM dithiothreitol). Finally, proteins were concentrated to >10 mg ml -1 using Amicon Ultra-15 Centrifugal Filters (Millipore). The PmSPS1, PmSPS2 and PmCHS proteins purified as homodimers, while Pm4CL1, PmKOMT1, PmKOMT2 and PmKLR1 purified as monomers.
PmKLR1 site-directed mutagenesis. Two overlapping gene fragments were separately amplified by PCR from the plasmid containing PmKLR1 as template using primers containing the desired single-amino-acid substitutions (see Supplementary Table 4 ). The two fragments were simultaneously cloned into the pHis8-4 target vector using Gibson assembly 58 .
In vitro enzyme assays. Enzyme assays were performed in 50 mM potassium phosphate buffer, pH 7.6 containing 5 mM MgCl 2 , 3 mM adenosine triphosphate, 1 mM coenzyme A, 3 mM malonyl-CoA and 0.25 mM initial substrate (typically, cinnamic acid or p-coumaric acid). Recombinant enzymes were added to final concentration of 10 µg ml -1
. For OMT assays, additional 3 mM S-adenosylmethionine was added. For reductase assays, additional 5 mM NADPH was added. Reactions were incubated at 30 °C until completion (typically overnight), followed by the addition of methanol to 50% final concentration. Samples were centrifuged (13,000g, 20 min) and supernatants were collected for LC-MS analyses.
Stereo-specific deuterium labelling using NADPH isotopic analogues. Enzyme assays using site specifically deuterium-labelled NADPH isotopic analogues 60 were performed as coupled reactions where additional components were added to produce the desired NADPH isotopic analogue. Transgenic Arabidopsis. Kava PKS genes were cloned into the pEarleyGate 100 vector 61 and transformed into Agrobacterium tumefaciens strain GV3130. The A. thaliana tt4-2 mutant 28 was then transformed using the Agrobacterium-mediated floral dip method 62 . Transformants were selected by spraying with Finale (contains 11.33% glufosinate ammonium; Bayer) diluted 1:500 in water. Selection was repeated in each subsequent generation and experiments were performed in the T 2 or T 3 generations, as indicated in Supplementary Fig. 2 .
Quantitative PCR analysis. qRT-PCR reactions were performed on a QuantStudio 6 Flex system (Thermo Fisher Scientific) using SYBR Green Master Mix (Thermo Fisher Scientific) and primers listed in Supplementary Table 4 . Gene expression cycle threshold (Ct) values were normalized using the reference gene At1g13320 (ref. 63 ).
Plant metabolite extraction.
Approximately 100 mg of plant leaf tissue was dissected, transferred into grinding tubes containing ~15 zirconia/silica disruption beads (2 mm diameter; Research Products International) and snap-frozen in liquid nitrogen. The frozen samples were homogenized twice on a TissueLyser II (QIAGEN). Metabolites were extracted using 5-10 volumes (w/v) of 50% methanol at 55 °C for 1 h. Extracts were centrifuged twice (13,000g, 20 min) and supernatants were collected for LC-MS analysis.
LC-MS analysis. LC was conducted on a Dionex UltiMate 3000 UHPLC system (Thermo Fisher Scientific), using water with 0.1% formic acid as solvent A and acetonitrile with 0.1% formic acid as solvent B. Reverse phase separation of analytes was performed on a Kinetex C18 column, 150 × 3 mm 2 , 2.6 μm particle size (Phenomenex). Chiral chromatography was performed on a Lux i-Amylose-1 column, 250 × 4.6 mm 2 , 5 µm particle size (Phenomenex). The column oven was held at 30 °C. Most injections were eluted with a gradient of 5-60% B for 9 min, 95% B for 3 min and 5% B for 3 min, with a flow rate of 0.7 ml min -1 . The initial analysis of Piper species leaf extracts was performed on a gradient of 5-80% B for 40 min, 95% B for 4 min and 5% B for 5 min, with a flow rate of 0.8 ml min -1 . Chiral chromatography was performed on a gradient of 5-95% B for 30 min, 95% B for 5 min and 5% B for 10 min, with a flow rate of 1 ml min -1 . MS analyses for the OMT enzyme screen and for chiral chromatography were performed on a TSQ Quantum Access Max mass spectrometer (Thermo Fisher Scientific) operated in positive ionization mode with full scan range of 100-400 m/z. Other MS analyses and plant metabolic profiling were performed on a high-resolution Q-Exactive benchtop Orbitrap mass spectrometer (Thermo Fisher Scientific) operated in positive ionization mode with full scan range of 100-1000 m/z and top five data-dependent MS/MS scans. Raw LC-MS data were analysed using XCalibur (Thermo Fisher Scientific), MZmine 2 (ref. 64 ) and MetaboAnalyst 65 . The SIRIUS tool was used to interpret MS/MS spectra 66, 67 . Identified metabolites are listed in Supplementary Table 3 .
X-ray crystallography. The purified PmSPS1 protein (17.1 mg ml PmCHS and PmKLR1 X-ray diffraction data were collected on the 24-ID-E beam line equipped with an Eiger-16M pixel array detector (Advanced Photon Source, Argonne National Laboratory). Diffraction intensities were indexed and integrated with iMosflm 68 and scaled with SCALA 69 . Initial phases were determined by molecular replacement using Phaser 70 in PHENIX 71 , using search models generated from protein sequences on the Phyre 2 server 72 . Subsequent structural building and refinements were conducted in PHENIX. Coot was used for graphical map inspection and manual tuning of atomic models 73 . Root mean square deviation (RMSD) of PmSPS1 and PmCHS structures was calculated using the structure comparison function in PHENIX. Crystallography statistics are listed in Supplementary Table 2 . The average B-factor in the PmKLR1 structure was higher than usual due to a number of flexible or disordered regions present in chains A and D of the structure (residues 91-97, 133-143, 212-226, 243-250 and 256-292).
Protein structure modelling, docking and rendering. The PmSPS2 structure model was generated on the Phyre 2 server using the PmSPS1 crystal structure as a modelling template 72 . The active-site pocket in the PmSPS1 structure was determined using KVFinder 74 . Ligand docking calculations were performed with AutoDock Vina 1.1.2 (ref. 75 ). Molecular graphics were rendered with PyMOL 2.0.7 (Schrödinger).
Transient expression in N. benthamiana. Target kava genes were cloned into the pEAQ-HT vector 76, 77 Reconstitution of styrylpyrone biosynthesis in E. coli. Pm4CL1, PmSPS1 and PmSPS2 were cloned into a custom-made, operon-like expression vector pJKW1565. The genes were preceded by a constitutively expressed pGAP promoter of the E. coli glyceraldehyde-3-phosphate dehydrogenase (GAPDH) 79 , and each gene was preceded by a 23-bp ribosome binding site sequence 80 . tSPY was used as a terminator 81 . The constructed plasmids (pJKW1574 containing the Pm4CL1+PmSPS1 operon and pJKW1658 containing the Pm4CL1+PmSPS2 operon) were transformed into the BW27784 E. coli strain 82 and cultivated at 30 °C overnight in TB medium supplied with 1 mM p-coumaric acid, followed by metabolite extraction from the culture fluid. An aliquot of the bacterial culture was mixed with an equal volume of methanol (50% final methanol concentration), centrifuged twice (13,000g, 20 min) and supernatants were collected for LC-MS analysis. Since bisnoryangonin standard was not available, its concentrations were estimated using naringenin as the calibration-curve standard.
Reconstitution of styrylpyrone biosynthesis in S. cerevisiae. The p42xTEF 2µ plasmids with various auxotrophic growth markers for constitutive expression in yeast were used 83 . The Pm4CL1 gene was cloned into p425TEF (plasmid pJKW1413), while PmSPS1 and PmSPS2 were cloned into p426TEF (plasmids pJKW1538 and pJKW1547, respectively). The constructed plasmids were transformed into the BY4743 yeast strain 84 . Yeast cells were cultivated at 30 °C for 2 d in Yeast Nitrogen Base + histidine + dextrose medium supplied with 2 mM p-coumaric acid, followed by metabolite extraction from the culture fluid. An aliquot of the yeast culture was mixed with an equal volume of methanol (50% final methanol concentration), centrifuged twice (13,000g, 20 min) and supernatants were collected for LC-MS analysis. Since bisnoryangonin standard was not available, its concentrations were estimated using naringenin as the calibrationcurve standard.
Reporting Summary. Further information on research design is available in the Nature Research Reporting Summary linked to this article.
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